Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors.

作者: Kamala K. Vasu , Chander Singh Digwal , Amit N. Pandya , Dhaivat H. Pandya , Jayesh A. Sharma

DOI: 10.1016/J.BMCL.2017.10.060

关键词:

摘要: A series of new imidazo[1,2-a]pyridine linked with thiazole/thiophene motif through a keto spacer were synthesized and tested for their cytotoxic potential against three human cancer cell lines including A549, HeLa U87-MG using MTT assay. Compounds A2, A3, A4, C1 C2 showed cytotoxicity all the lines. The selectivity index compound A4 A549 cells was comparable to that doxorubicin. Among compounds, B5 maximum inhibition NF-κB activity as ascertained by reporter assay (IC50 = 6.5 ± 0.6 µM). Treatment NCI-H23 (EGFR overexpressed, KRAS G12V mutant) erlotinib gefitinib along compounds indicated synergistic additive combination therapy.

参考文章(40)
Giuseppe Giaccone, Ariel Lopez-Chavez, Corey A. Carter, The role of KRAS mutations in resistance to EGFR inhibition in the treatment of cancer. Current opinion in investigational drugs. ,vol. 10, pp. 1305- 1314 ,(2009)
Markian M. Stec, Kristin L. Andrews, Yunxin Bo, Sean Caenepeel, Hongyu Liao, John McCarter, Erin L. Mullady, Tisha San Miguel, Raju Subramanian, Nuria Tamayo, Douglas A. Whittington, Ling Wang, Tian Wu, Leeanne P. Zalameda, Nancy Zhang, Paul E. Hughes, Mark H. Norman, The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors. Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 4136- 4142 ,(2015) , 10.1016/J.BMCL.2015.08.016
Mollie K Meffert, Jolene M Chang, Brian J Wiltgen, Michael S Fanselow, David Baltimore, None, NF-κB functions in synaptic signaling and behavior Nature Neuroscience. ,vol. 6, pp. 1072- 1078 ,(2003) , 10.1038/NN1110
Takanobu Kobayashi, Atsushi Yoshimori, Katsuhito Kino, Rie Komori, Hiroshi Miyazawa, Sei-ich Tanuma, A new small molecule that directly inhibits the DNA binding of NF-κB Bioorganic & Medicinal Chemistry. ,vol. 17, pp. 5293- 5297 ,(2009) , 10.1016/J.BMC.2009.05.030
Ki-Young Moon, Bum-Soo Hahn, Jinseon Lee, Yeong Shik Kim, A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells Analytical Biochemistry. ,vol. 292, pp. 17- 21 ,(2001) , 10.1006/ABIO.2001.5059
William C. Hahn, Robert A. Weinberg, Rules for making human tumor cells. The New England Journal of Medicine. ,vol. 347, pp. 1593- 1603 ,(2002) , 10.1056/NEJMRA021902
T D Gilmore, Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. ,vol. 25, pp. 6680- 6684 ,(2006) , 10.1038/SJ.ONC.1209954
Mahabaleshwaraiah Neelgundmath, Koragere Rajashekar Dinesh, Chakrabhavi Dhananjaya Mohan, Feng Li, Xiaoyun Dai, Kodappully Sivaraman Siveen, Shardul Paricharak, Daniel J. Mason, Julian E. Fuchs, Gautam Sethi, Andreas Bender, Kanchugarakoppal S. Rangappa, Obelannavar Kotresh, Basappa, Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma Bioorganic & Medicinal Chemistry Letters. ,vol. 25, pp. 893- 897 ,(2015) , 10.1016/J.BMCL.2014.12.065
Masahiko Hayakawa, Ken-ichi Kawaguchi, Hiroyuki Kaizawa, Tomonobu Koizumi, Takahide Ohishi, Mayumi Yamano, Minoru Okada, Mitsuaki Ohta, Shin-ichi Tsukamoto, Florence I Raynaud, Peter Parker, Paul Workman, Michael D Waterfield, Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2 -a]pyridines as novel PI3 kinase p110α inhibitors Bioorganic & Medicinal Chemistry. ,vol. 15, pp. 5837- 5844 ,(2007) , 10.1016/J.BMC.2007.05.070